BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1082 related articles for article (PubMed ID: 29981289)

  • 1. LncRNA HOXA-AS2 and its molecular mechanisms in human cancer.
    Wang J; Su Z; Lu S; Fu W; Liu Z; Jiang X; Tai S
    Clin Chim Acta; 2018 Oct; 485():229-233. PubMed ID: 29981289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Upregulation of long non-coding RNA HOXA-AS2 promotes proliferation and induces epithelial-mesenchymal transition in gallbladder carcinoma.
    Zhang P; Cao P; Zhu X; Pan M; Zhong K; He R; Li Y; Jiao X; Gao Y
    Oncotarget; 2017 May; 8(20):33137-33143. PubMed ID: 28388535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HOX Antisense lincRNA HOXA-AS2 Promotes Tumorigenesis of Hepatocellular Carcinoma.
    Wang F; Yang H; Deng Z; Su Y; Fang Q; Yin Z
    Cell Physiol Biochem; 2016; 40(1-2):287-296. PubMed ID: 27855366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long non-coding RNA HOXA-AS2 promotes proliferation and invasion of breast cancer by acting as a miR-520c-3p sponge.
    Fang Y; Wang J; Wu F; Song Y; Zhao S; Zhang Q
    Oncotarget; 2017 Jul; 8(28):46090-46103. PubMed ID: 28545023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LncRNA HOXA-AS2 Promotes Oral Squamous Cell Proliferation, Migration, and Invasion via Upregulating EZH2 as an Oncogene.
    Zhao Z; Xing Y; Yang F; Zhao Z; Shen Y; Song J; Jing S
    Technol Cancer Res Treat; 2021; 20():15330338211039109. PubMed ID: 34519570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of long non-coding RNA AFAP1-AS1 in human malignant tumors.
    Ji D; Zhong X; Jiang X; Leng K; Xu Y; Li Z; Huang L; Li J; Cui Y
    Pathol Res Pract; 2018 Oct; 214(10):1524-1531. PubMed ID: 30173945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LncRNA HOXA-AS2 promotes the progression of prostate cancer via targeting miR-509-3p/PBX3 axis.
    Xiao S; Song B
    Biosci Rep; 2020 Aug; 40(8):. PubMed ID: 32519740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long non-coding RNA HOXA-AS2 promotes the migration, invasion and stemness of bladder cancer via regulating miR-125b/Smad2 axis.
    Wang F; Wu D; Chen J; Chen S; He F; Fu H; Wu Q; Liu S; Li X; Wang W
    Exp Cell Res; 2019 Feb; 375(1):1-10. PubMed ID: 30412716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long noncoding RNA HOXA-AS2 promotes gastric cancer proliferation by epigenetically silencing P21/PLK3/DDIT3 expression.
    Xie M; Sun M; Zhu YN; Xia R; Liu YW; Ding J; Ma HW; He XZ; Zhang ZH; Liu ZJ; Liu XH; De W
    Oncotarget; 2015 Oct; 6(32):33587-601. PubMed ID: 26384350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HOTTIP: a critical oncogenic long non-coding RNA in human cancers.
    Lian Y; Cai Z; Gong H; Xue S; Wu D; Wang K
    Mol Biosyst; 2016 Oct; 12(11):3247-3253. PubMed ID: 27546609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The lncRNA-HOXA-AS2/EZH2/LSD1 oncogene complex promotes cell proliferation in pancreatic cancer.
    Lian Y; Li Z; Fan Y; Huang Q; Chen J; Liu W; Xiao C; Xu H
    Am J Transl Res; 2017; 9(12):5496-5506. PubMed ID: 29312501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PANDAR: a pivotal cancer-related long non-coding RNA in human cancers.
    Li J; Li Z; Zheng W; Li X; Wang Z; Cui Y; Jiang X
    Mol Biosyst; 2017 Oct; 13(11):2195-2201. PubMed ID: 28976505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of long noncoding RNA HOXA-AS2 predicts an adverse prognosis and promotes tumorigenesis via SOX4/PI3K/AKT pathway in acute myeloid leukemia.
    Qu Y; Wang Y; Wang P; Lin N; Yan X; Li Y
    Cell Biol Int; 2020 Aug; 44(8):1745-1759. PubMed ID: 32369230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long noncoding RNA HOXA-AS2 promotes cell migration and invasion via upregulating IGF-2 in non-small cell lung cancer as an oncogene.
    Zheng FX; Wang XQ; Zheng WX; Zhao J
    Eur Rev Med Pharmacol Sci; 2019 Jun; 23(11):4793-4799. PubMed ID: 31210310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ARID1B/SUB1-activated lncRNA HOXA-AS2 drives the malignant behaviour of hepatoblastoma through regulation of HOXA3.
    Liu G; Liu B; Liu X; Xie L; He J; Zhang J; Dong R; Ma D; Dong K; Ye M
    J Cell Mol Med; 2021 Apr; 25(7):3524-3536. PubMed ID: 33683826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LncRNA HOXA-AS2 Facilitates Tumorigenesis and Progression of Papillary Thyroid Cancer by Modulating the miR-15a-5p/HOXA3 Axis.
    Jiang L; Wu Z; Meng X; Chu X; Huang H; Xu C
    Hum Gene Ther; 2019 May; 30(5):618-631. PubMed ID: 30375256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LncRNA-ATB: An indispensable cancer-related long noncoding RNA.
    Li J; Li Z; Zheng W; Li X; Wang Z; Cui Y; Jiang X
    Cell Prolif; 2017 Dec; 50(6):. PubMed ID: 28884871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long noncoding RNA HOXA-AS2 functions as an oncogene by binding to EZH2 and suppressing LATS2 in acute myeloid leukemia (AML).
    Feng Y; Hu S; Li L; Peng X; Chen F
    Cell Death Dis; 2020 Dec; 11(12):1025. PubMed ID: 33268767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TCF7L2 activated HOXA-AS2 decreased the glucocorticoid sensitivity in acute lymphoblastic leukemia through regulating HOXA3/EGFR/Ras/Raf/MEK/ERK pathway.
    Zhao Q; Zhao S; Li J; Zhang H; Qian C; Wang H; Liu J; Zhao Y
    Biomed Pharmacother; 2019 Jan; 109():1640-1649. PubMed ID: 30551418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oncogenicity of lncRNA FOXD2-AS1 and its molecular mechanisms in human cancers.
    Hu Q; Tai S; Wang J
    Pathol Res Pract; 2019 May; 215(5):843-848. PubMed ID: 30723052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 55.